Literature DB >> 9369927

Relationship between the nature of mucus and crypt multiplicity in aberrant crypt foci in the rat colon.

K Uchida1, S Kado, M Onoue, K Tohyama.   

Abstract

Aberrant crypt foci (ACF) induced in the distal colon of F344 male rats, 4, 8, 12 and 35 weeks after the first administration of 1, 2-dimethylhydrazine-2HCl (DMH) were examined to determine whether a correlation exists between the nature of goblet cell mucin and the number of crypts (crypt multiplicity) comprising the ACF. According to the ACF score calculated from the results of the qualitative observation of sulfomucins (SuMs) and sialomucins (SiMs), the ACF in the 4th week showed a weak correlation between the nature of the mucus and crypt multiplicity, and the ACF of each class showed similar mucous profiles. From the 8th week, a significant difference (P < 0.01) was recognized between the ACF consisting of 3 crypts or less and those consisting of 4 crypts or more. The proportion of crypts with SiM predominance showed a decrease in the 8th week in the ACF consisting of 1 crypt and in the 12th week in the ACF consisting of 2 or 3 crypts, implying a recovery tendency. The ACF consisting of more than 4 crypts showed little change over time, retaining the tendency of SiM predominance. Ulex europaeus agglutinin-I (UEA-I) lectin-positive crypts appeared in the ACF. This finding was significantly more prominent (P < 0.001) in the ACF with SiM predominance than in the ACF with SuM predominance at each experimental period, and in the 12th week after the first administration of DMH, the incidence of ACF with UEA-I-reactive mucin was decreased in the ACF groups consisting of 3 crypts or less, compared with the ACF groups consisting of 4 or more crypts. These results suggest that the biological quality of mucus in ACF consisting of 4 or more crypts is different from that in ACF consisting of 3 crypts or less. This difference should be considered when ACF are used as an intermediate biomarker of colon cancer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9369927      PMCID: PMC5921510          DOI: 10.1111/j.1349-7006.1997.tb00455.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  23 in total

1.  The role of aberrant crypt foci induced by the two heterocyclic amines 2-amino-3-methyl-imidazo[4,5-f]quinoline (IQ) and 2-amino-1-methyl-6-phenyl-imidazo[4,5-b]pyridine (PhIP) in the development of colon cancer in mice.

Authors:  E Kristiansen
Journal:  Cancer Lett       Date:  1996-12-20       Impact factor: 8.679

2.  Enzyme-altered foci in colons of carcinogen-treated rats.

Authors:  B J Barrow; M A O'Riordan; T A Stellato; B M Calkins; T P Pretlow
Journal:  Cancer Res       Date:  1990-03-15       Impact factor: 12.701

3.  Ulex europeus agglutinin I binding pattern during chemical carcinogenesis in the rat gastrointestinal tract.

Authors:  S Carraro; S Hamamura; O Tiscornia; D Celener; F G Celener; L B Fernandez
Journal:  Cancer       Date:  1993-08-01       Impact factor: 6.860

4.  DNA adduct formation and assessment of aberrant crypt foci in vivo in the rat colon mucosa after treatment with N-methyl-N-nitrosourea.

Authors:  X Qin; M Zarkovic; Y Nakatsuru; M Arai; H Oda; T Ishikawa
Journal:  Carcinogenesis       Date:  1994-05       Impact factor: 4.944

5.  Ulex europaeus agglutinin-1 binding in hereditary bowel cancer.

Authors:  J R Jass; L J Allison; S M Stewart; M R Lane
Journal:  Pathology       Date:  1993-04       Impact factor: 5.306

6.  Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate.

Authors:  T P Pretlow; M A O'Riordan; G A Somich; S B Amini; T G Pretlow
Journal:  Carcinogenesis       Date:  1992-09       Impact factor: 4.944

7.  Glycoconjugate with Ulex europaeus agglutinin-I-binding sites in normal mucosa, adenoma, and carcinoma of the human large bowel.

Authors:  S Yonezawa; T Nakamura; S Tanaka; E Sato
Journal:  J Natl Cancer Inst       Date:  1982-10       Impact factor: 13.506

8.  Role of morphological methods in the analysis of chemically induced colon cancer in rats.

Authors:  I Zusman; A Zimber; A Nyska
Journal:  Acta Anat (Basel)       Date:  1991

9.  Mucous secretion in rat colonic mucosa during carcinogenesis induced by dimethylhydrazine. A morphological and histochemical study.

Authors:  M I Filipe
Journal:  Br J Cancer       Date:  1975-07       Impact factor: 7.640

10.  Expression of sulfomucins in normal mucosae, colorectal adenocarcinomas, and metastases.

Authors:  Y Matsushita; N Yamamoto; H Shirahama; S Tanaka; S Yonezawa; T Yamori; T Irimura; E Sato
Journal:  Jpn J Cancer Res       Date:  1995-11
View more
  2 in total

1.  Abnormal Savda Munziq, an Herbal Preparation of Traditional Uighur Medicine, May Prevent 1,2-dimethylhydrazine-Induced Rat Colon Carcinogenesis.

Authors:  Abdiryim Yusup; Halmurat Upur; Anwar Umar; Benedicte Berke; Dilxat Yimit; Jaya Conser Lapham; Nicholas Moore; Pierrette Cassand
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-16       Impact factor: 2.629

Review 2.  A mini-review on the impact of common gorse in its introduced ranges.

Authors:  Hansani S S Daluwatta Galappaththi; W A Priyanka P de Silva; Andrea Clavijo Mccormick
Journal:  Trop Ecol       Date:  2022-05-02       Impact factor: 1.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.